Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity.
Saved in:
| Title: | Diffusion abnormalities of the corpus callosum in patients receiving bevacizumab for malignant brain tumors: suspected treatment toxicity. |
|---|---|
| Authors: | Futterer SF; Neuroradiology Section, Department of Radiology, Northwestern Memorial Hospital, Northwestern University, 676 N. Saint Clair St., Ste. # 1400, Chicago, IL, USA., Nemeth AJ, Grimm SA, Ragin AB, Chandler JP, Muro K, Marymont MH, Raizer JJ |
| Source: | Journal of neuro-oncology [J Neurooncol] 2014 May; Vol. 118 (1), pp. 147-53. Date of Electronic Publication: 2014 Feb 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
